Such novel findings indicated that bladder cancer cells enhanced CXCL9 in TADCs, which significantly up-regulated PD-L1 expression in cancer cells by activating the CXCR3-related STAT3/Akt signaling. Here, STAT3 is linked to urinary bladder carcinoma.